v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04753476 |
Full text link
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
dr.agungptr@gmail.com |
Registration date
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2021-02-15 |
Recruitment status
Last imported at : May 8, 2023, midnight Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: patients whose clinical and laboratory test results have a positive diagnosis of covid-19. patients who are willing to participate as subjects in the study by signing the informed content. criteria for berlin to enter ards (moderate and severe) with or without a ventilator: pao2 / fio2: moderate 100-200 pao2 / fio2: severe <100 one or more comorbid history sofa score |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
the covid19 patient has fibrosis (based on the results of the chest x-ray or ct chest) ecog 4 performance status, decreased irreversible consciousness, brain stem death. severe nyha iii / iv heart failure pregnant women |
Number of arms
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Stem Cell and Cancer Research Indonesia |
Inclusion age min
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2 |
Inclusion age max
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Indonesia |
Type of patients
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Severe/critical disease at enrollment |
Severity scale
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
7: Severe/critical disease at enrollment |
Total sample size
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
48 |
primary outcome
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Blood Gas Analisis (BGA);Change in patients clinical manifestation;CRP;D-dimer;Duration of using a ventilator;Length of stay;Need for a ventilator;Photo thorax;Routine blood profile |
Notes
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : Feb. 17, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1176, "treatment_name": "Secretome-mscs", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |